Bladder cancer: Natural history, tumor markers, and early detection strategies

被引:0
|
作者
Foresman, WH [1 ]
Messing, EM [1 ]
机构
[1] UNIV ROCHESTER, STRONG MEM HOSP, DEPT UROL, ROCHESTER, NY 14642 USA
来源
SEMINARS IN SURGICAL ONCOLOGY | 1997年 / 13卷 / 05期
关键词
bladder neoplasms; carcinoma in situ; transitional cell carcinoma; hematuria; urothelium; tumor suppressor genes; p53; gene; retinoblastoma protein; neoplasm invasiveness; antigens; biological tumor markers; oncogenes;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transitional cell bladder carcinoma is characterized by a dichotomous, multichronotopic natural history. Low and moderate grade Ta lesions frequently recur, yet rarely invade, and carry an excellent prognosis with currently available treatments. High grade Ta lesions, tumors with lamina propria invasion (T1), and carcinoma in situ often progress to invasive disease, at which time overall prognosis is significantly decreased, despite various treatment alternatives. Although early detection of bladder tumors, prior to muscle invasion, should vastly improve our ability to save both bladders and lives, current methods of detection are neither sufficiently sensitive nor specific. Tumor marker analysis is an exciting new frontier in bladder cancer evaluation, and may have important applications to early detection strategies, in combination with simple hematuria testing and other selected noninvasive screening methods. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 50 条
  • [11] Prognostic markers for bladder cancer:: International consensus panel on bladder tumor markers
    Habuchi, T
    Marberger, M
    Droller, MJ
    Hemstreet, GP
    Grossman, HB
    Schalken, JA
    Schmitz-Dräger, BJ
    Murphy, WM
    Bono, AV
    Goebell, P
    Getzenberg, RH
    Hautmann, SH
    Messing, E
    Fradet, Y
    Lokeshwar, VB
    UROLOGY, 2005, 66 (6A) : 64 - 74
  • [12] An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies
    ul Quraish, Reeshan
    Hirahata, Tetsuyuki
    ul Quraish, Afraz
    ul Quraish, Shahan
    CANCER INFORMATICS, 2023, 22
  • [13] An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies
    ul Quraish, Reeshan
    Hirahata, Tetsuyuki
    ul Quraish, Afraz
    ul Quraish, Shahan
    CANCER INFORMATICS, 2023, 22
  • [14] Current concepts of tumor markers in bladder cancer
    Droller, MJ
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 229 - +
  • [15] TUMOR-MARKERS IN BLADDER-CANCER
    HUBEN, RP
    UROLOGY, 1984, 23 (03) : 10 - 14
  • [16] NATURAL-HISTORY AND EARLY DETECTION OF PROSTATE-CANCER
    SCARDINO, PT
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (09) : S107 - S107
  • [17] Urine markers for detection and surveillance of bladder cancer
    Xylinas, Evanguelos
    Kluth, Luis A.
    Rieken, Malte
    Karakiewicz, Pierre I.
    Lotan, Yair
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (03) : 222 - 229
  • [18] INFERRING THE NATURAL TIME HISTORY OF BREAST-CANCER - IMPLICATIONS FOR TUMOR-GROWTH RATE AND EARLY DETECTION
    FELDSTEIN, M
    ZELEN, M
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (01) : 3 - 10
  • [19] New molecular markers for bladder cancer detection
    Quek, ML
    Sanderson, K
    Daneshmand, S
    Stein, JP
    CURRENT OPINION IN UROLOGY, 2004, 14 (05) : 259 - 264
  • [20] Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
    Jia-You Lin
    Bao-Rong Juo
    Yu-Hsuan Yeh
    Shu-Hsuan Fu
    Yi-Ting Chen
    Chien-Lun Chen
    Kun-Pin Wu
    BMC Bioinformatics, 22